Clinical Trial Update: Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C [Phase 2]

View source ↗

Summary

This Phase 2 study evaluated the efficacy and safety of Inclisiran in Japanese participants at high cardiovascular risk with elevated LDL-C. The trial completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heterozygous Familial Hypercholesterolemia
• Hypercholesterolemia

Drugs mentioned

• Inclisiran (inclisiran)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia | Phase 2 | Status: COMPLETED | Results posted: 2023-05-10